Literature DB >> 22642889

Early cognitive dysfunction in the HD 51 CAG transgenic rat model of Huntington's disease.

Kyle D Fink1, Julien Rossignol, Andrew T Crane, Kendra K Davis, Angela M Bavar, Nicholas W Dekorver, Steven A Lowrance, Mark P Reilly, Michael I Sandstrom, Stephan von Hörsten, Laurent Lescaudron, Gary L Dunbar.   

Abstract

Huntington's disease (HD) is a neurodegenerative disorder in humans caused by an expansion of a CAG trinucleotide repeat that produces choreic movements, which are preceded by cognitive deficits. The HD transgenic rat (tgHD), which contains the human HD mutation with a 51 CAG repeat allele, exhibits motor deficits that begin when these rats are 12 months of age. However, there are no reports of cognitive dysfunction occurring prior to this. To assess whether cognitive dysfunction might precede motor deficits in tgHD rats, one group of 9-month-old male rats with homozygotic mutated genes and one group of wild-type (WT) rats underwent three testing phases in a unique Spatial Operant Reversal Test (SORT) paradigm, as well as assessment of spontaneous motor activity. After testing, morphological and histological examination of the brains were made. Results indicated that tgHD rats acquired the cued-response (Phase 1) portion of the SORT, but made significantly more errors during the reversal (Phase 2) and during the pseudorandomized reversals (Phase 3) portion of the study, when compared to WT rats. Analysis of the data using mathematical principles of reinforcement revealed no memory, motor, or motivational deficits. These results indicate that early cognitive dysfunction, as measured by the SORT, occur prior to motor deficits, gross anatomical changes, or cell loss in the tgHD rat with 51 CAG repeats, and suggest that this protocol could provide a useful screen for therapeutic studies.
© 2012 American Psychological Association

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22642889     DOI: 10.1037/a0028028

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  9 in total

1.  Onset of Huntington's disease: can it be purely cognitive?

Authors:  Jane S Paulsen; Jeffrey D Long
Journal:  Mov Disord       Date:  2014-08-20       Impact factor: 10.338

2.  The Allure of High-Risk Rewards in Huntington's disease.

Authors:  Nelleke C van Wouwe; Kristen E Kanoff; Daniel O Claassen; K Richard Ridderinkhof; Peter Hedera; Madaline B Harrison; Scott A Wylie
Journal:  J Int Neuropsychol Soc       Date:  2015-12-28       Impact factor: 2.892

Review 3.  Risk-taking and pathological gambling behavior in Huntington's disease.

Authors:  Carla Kalkhoven; Cor Sennef; Ard Peeters; Ruud van den Bos
Journal:  Front Behav Neurosci       Date:  2014-04-02       Impact factor: 3.558

4.  Impaired Decision Making and Loss of Inhibitory-Control in a Rat Model of Huntington Disease.

Authors:  Nicole El Massioui; Charlotte Lamirault; Sara Yagüe; Najia Adjeroud; Daniel Garces; Alexis Maillard; Lucille Tallot; Libo Yu-Taeger; Olaf Riess; Philippe Allain; Huu Phuc Nguyen; Stephan von Hörsten; Valérie Doyère
Journal:  Front Behav Neurosci       Date:  2016-10-26       Impact factor: 3.558

Review 5.  Dysregulation of Corticostriatal Connectivity in Huntington's Disease: A Role for Dopamine Modulation.

Authors:  Claudia Rangel-Barajas; George V Rebec
Journal:  J Huntingtons Dis       Date:  2016-12-15

6.  Assessment of motor function, sensory motor gating and recognition memory in a novel BACHD transgenic rat model for huntington disease.

Authors:  Yah-Se K Abada; Huu Phuc Nguyen; Rudy Schreiber; Bart Ellenbroek
Journal:  PLoS One       Date:  2013-07-11       Impact factor: 3.240

7.  Reversal learning and associative memory impairments in a BACHD rat model for Huntington disease.

Authors:  Yah-Se K Abada; Huu Phuc Nguyen; Bart Ellenbroek; Rudy Schreiber
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

8.  Transgenic rat model of Huntington's disease: a histopathological study and correlations with neurodegenerative process in the brain of HD patients.

Authors:  Yvona Mazurová; Miroslava Anderova; Ivana Němečková; Aleš Bezrouk
Journal:  Biomed Res Int       Date:  2014-08-03       Impact factor: 3.411

Review 9.  Developing stem cell therapies for juvenile and adult-onset Huntington's disease.

Authors:  Kyle D Fink; Peter Deng; Audrey Torrest; Heather Stewart; Kari Pollock; William Gruenloh; Geralyn Annett; Teresa Tempkin; Vicki Wheelock; Jan A Nolta
Journal:  Regen Med       Date:  2015       Impact factor: 3.806

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.